Patent · US Active

Detection method of polyethylene glycol monomethyl ether residue in medicinal materials

US11946917B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2020
Grant dateApr 2, 2024
Priority date
Expiry dateFeb 2, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/885
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A detection method of polyethylene glycol monomethyl ether residue in medicinal materials is provided, which belongs to a technical field of medicinal chemical component detection, and includes: detecting a residual amount of mPEG-2000 in 3000-3400 small-molecule mPEG-b-PDLLA by high-performance liquid chromatography with an evaporative light scattering detector. The present invention solves a problem that the copolymer polyethylene glycol monomethyl ether mPEG and the product polyethylene glycol monomethyl ether-polylactic acid block copolymer mPEG-b-PDLLA are difficult to be separated in the high-performance liquid chromatography and there is no UV absorption. The present invention also has high resolution, high sensitivity, sufficient reproducibility and sufficient selectivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.